B Nosyk1, L Li2, E Evans2, D Huang2, J Min3, T Kerr4, M L Brecht2, Y I Hser5. 1. BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia V6Z 2C7, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada; UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA. 2. UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA. 3. BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia V6Z 2C7, Canada. 4. BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia V6Z 2C7, Canada; Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada. 5. UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA. Electronic address: yhser@ucla.edu.
Abstract
AIMS: Characterize longitudinal patterns of drug use careers and identify determinants of drug use frequency across cohorts of primary heroin, methamphetamine (MA) and cocaine users. DESIGN: Pooled analysis of prospective cohort studies. SETTINGS: Illicit drug users recruited from community, criminal justice and drug treatment settings in California, USA. PARTICIPANTS: We used longitudinal data on from five observational cohort studies featuring primary users of heroin (N=629), cocaine (N=694) and methamphetamine (N=474). The mean duration of follow-up was 20.9 years. MEASUREMENTS: Monthly longitudinal data was arranged according to five health states (incarceration, drug treatment, abstinence, non-daily and daily use). We fitted proportional hazards (PH) frailty models to determine independent differences in successive episode durations. We then executed multi-state Markov (MSM) models to estimate probabilities of transitioning between health states, and the determinants of these transitions. FINDINGS: Across primary drug use types, PH frailty models demonstrated durations of daily use diminished in successive episodes over time. MSM models revealed primary stimulant users had more erratic longitudinal patterns of drug use, transitioning more rapidly between periods of treatment, abstinence, non-daily and daily use. MA users exhibited relatively longer durations of high-frequency use. Criminal engagement had a destabilizing effect on health state durations across drug types. Longer incarceration histories were associated with delayed transitions toward cessation. CONCLUSIONS: PH frailty and MSM modeling techniques provided complementary information on longitudinal patterns of drug abuse. This information can inform clinical practice and policy, and otherwise be used in health economic simulation models, designed to inform resource allocation decisions. Published by Elsevier Ireland Ltd.
AIMS: Characterize longitudinal patterns of drug use careers and identify determinants of drug use frequency across cohorts of primary heroin, methamphetamine (MA) and cocaine users. DESIGN: Pooled analysis of prospective cohort studies. SETTINGS: Illicit drug users recruited from community, criminal justice and drug treatment settings in California, USA. PARTICIPANTS: We used longitudinal data on from five observational cohort studies featuring primary users of heroin (N=629), cocaine (N=694) and methamphetamine (N=474). The mean duration of follow-up was 20.9 years. MEASUREMENTS: Monthly longitudinal data was arranged according to five health states (incarceration, drug treatment, abstinence, non-daily and daily use). We fitted proportional hazards (PH) frailty models to determine independent differences in successive episode durations. We then executed multi-state Markov (MSM) models to estimate probabilities of transitioning between health states, and the determinants of these transitions. FINDINGS: Across primary drug use types, PH frailty models demonstrated durations of daily use diminished in successive episodes over time. MSM models revealed primary stimulant users had more erratic longitudinal patterns of drug use, transitioning more rapidly between periods of treatment, abstinence, non-daily and daily use. MA users exhibited relatively longer durations of high-frequency use. Criminal engagement had a destabilizing effect on health state durations across drug types. Longer incarceration histories were associated with delayed transitions toward cessation. CONCLUSIONS: PH frailty and MSM modeling techniques provided complementary information on longitudinal patterns of drug abuse. This information can inform clinical practice and policy, and otherwise be used in health economic simulation models, designed to inform resource allocation decisions. Published by Elsevier Ireland Ltd.
Entities:
Keywords:
Drug use careers; Health state transitions; Longitudinal; Multi-state Markov; Proportional hazards frailty
Authors: Fabian Termorshuizen; Anneke Krol; Maria Prins; Ronald Geskus; Wim van den Brink; Erik J C van Ameijden Journal: Drug Alcohol Depend Date: 2005-02-24 Impact factor: 4.492
Authors: Josiah D Rich; David A Wohl; Curt G Beckwith; Anne C Spaulding; Nathaniel E Lepp; Jacques Baillargeon; Adrian Gardner; Ann Avery; Frederick L Altice; Sandra Springer Journal: Curr HIV/AIDS Rep Date: 2011-12 Impact factor: 5.071
Authors: Bohdan Nosyk; Daphne P Guh; Nicholas J Bansback; Eugenia Oviedo-Joekes; Suzanne Brissette; David C Marsh; Evan Meikleham; Martin T Schechter; Aslam H Anis Journal: CMAJ Date: 2012-03-12 Impact factor: 8.262
Authors: Becky L Genberg; Stephen J Gange; Vivian F Go; David D Celentano; Gregory D Kirk; Carl A Latkin; Shruti H Mehta Journal: Addiction Date: 2011-07-27 Impact factor: 6.526
Authors: Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth Journal: Drug Alcohol Depend Date: 2018-05-22 Impact factor: 4.492
Authors: Emanuel Krebs; Jeong E Min; Elizabeth Evans; Libo Li; Lei Liu; David Huang; Darren Urada; Thomas Kerr; Yih-Ing Hser; Bohdan Nosyk Journal: Med Decis Making Date: 2016-12-27 Impact factor: 2.583
Authors: Magdalena Cerdá; Mohammad S Jalali; Ava D Hamilton; Catherine DiGennaro; Ayaz Hyder; Julian Santaella-Tenorio; Navdep Kaur; Christina Wang; Katherine M Keyes Journal: Epidemiol Rev Date: 2022-01-14 Impact factor: 6.222
Authors: Alexandra Savinkina; Rajapaksha W M A Madushani; Golnaz Eftekhari Yazdi; Jianing Wang; Joshua A Barocas; Jake R Morgan; Sabrina A Assoumou; Alexander Y Walley; Benjamin P Linas; Sean M Murphy Journal: Addiction Date: 2022-04-12 Impact factor: 7.256
Authors: Linwei Wang; Jeong Eun Min; Emanuel Krebs; Elizabeth Evans; David Huang; Lei Liu; Yih-Ing Hser; Bohdan Nosyk Journal: Int J Drug Policy Date: 2017-09-06